No Data
Weining Health: Report for the third quarter of 2024
Winning Health Technology Group (300253.SZ): The net income for the first three quarters was 0.155 billion yuan, a year-on-year increase of 1.51%.
Winning Health Technology Group (300253.SZ) released the third quarter report for 2024 on October 29th. In the first three quarters of 2024, the company achieved revenue of 1.913 billion yuan, a year-on-year increase of 0.65%; the net income attributable to shareholders of the listed company was 0.155 billion yuan, a year-on-year increase of 1.51%; the net income after deducting non-recurring gains and losses was 0.142 billion yuan, a year-on-year increase of 58.95%; and the basic earnings per share was 0.0716 yuan per share.
Winning Health Technology Group (SZSE:300253) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Increases 8.0% This Past Week
There's Reason For Concern Over Winning Health Technology Group Co., Ltd.'s (SZSE:300253) Massive 36% Price Jump
Is Winning Health Technology Group (SZSE:300253) Using Too Much Debt?
Winning Health Technology Group (300253.SZ): The asia vets intelligent assistant WiNEX Copilot based on WiNGPT is currently being used by pilot hospital users.
Winning Health Technology Group (300253.SZ) held a performance briefing on September 13, 2024, and discussed the specific application cases and achievements in the integration of emerging technologies such as artificial intelligence, big data, and medical health. The company stated that, for example, Winning Health has already launched the WiNEX Copilot, a medical and nursing intelligent assistant based on WiNGPT, for trial use by hospital users. The specific user names are not currently disclosed. In the future, the company will continue to strengthen technological and product innovation to promote business development.
Be Wary Of Winning Health Technology Group (SZSE:300253) And Its Returns On CapitalNo Data
No Data
